Lisbon, Portugal

Iris Duarte

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Iris Duarte in Particle Manufacturing

Introduction

Iris Duarte is an accomplished inventor based in Lisbon, Portugal. She has made significant contributions to the field of particle manufacturing, particularly in the continuous production of micro- and nanoparticles. Her innovative methods have the potential to enhance various applications in pharmaceuticals and materials science.

Latest Patents

Iris Duarte holds a patent for the continuous production of particles. This invention discloses a method to continuously manufacture micro- and/or nanoparticles of single component or multi-component particles, such as particulate amorphous solid dispersions or particulate co-crystals. The continuous method involves several steps, including preparing solutions, mixing them through microfluidization, and utilizing a filtration system followed by a spray dryer to obtain the desired particles. This innovative approach not only streamlines the manufacturing process but also improves the quality of the produced particles.

Career Highlights

Throughout her career, Iris has worked with notable companies, including Hovione Scientia Limited and Hovione International Limited. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in particle technology.

Collaborations

Iris has collaborated with talented individuals such as Tiago Fonseca and Márcio Temtem. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Iris Duarte's work in the continuous production of particles showcases her dedication to innovation in the field of particle manufacturing. Her contributions are paving the way for advancements in various industries, particularly in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…